Side effects and reactions after COVID-19 vaccines
DOI:
https://doi.org/10.62305/biosana.v4i4.206Keywords:
Coronavirus; diagnosis; epidemiology; clinical manifestations; treatmentAbstract
The covid-19 virus is caused by SARS cov2, a disease which affects the respiratory tract. This was discovered for the first time in Wuhan, China at the end of 2019, and the virus is spread by sneezing from an infected individual. Covid-19 vaccines come in a variety of forms, each including a unique combination of protein subunits, nucleic acids, viral vectors, and attenuated viruses. The adverse effects that manifest include soreness and pain in the puncture site. The main aim of this study was to analyze the side effects and reactions to COVID-19 vaccinations. A descriptive narrative methodology was applied based on a bibliographic search with inclusive and exclusive criteria. Several vaccinations with varying components that produced immunity more than 85% were tried as a first goal. With 96% of vaccinations used, messenger RNA vaccines were the most popular. Viral vector vaccines came in second with 90% of vaccinations, and the inactive virus vaccine with 79% immunity. The most common side effects of the vaccinations were chills, fever, arm soreness, and tenderness at the puncture site. As was the case with Pfizer and Moderna, the adverse reactions included lymphadenopathy, Bell's palsy, and nosebleeds, among other significant problems. There have been reports of thrombosis syndrome with thrombocytopenia and uncommon clotting disorders linked to the AstraZeneca and Johnson & Johnson vaccines.
Downloads
References
Trilla A. Un mundo, una salud: la epidemia por el nuevo coronavirus COVID-19. Elsevier. 2020; 154(5).
Miguel Ángel Acosta-Benito IML. Fragilidad en atención primaria: diagnóstico y manejo multidisciplinar. Elsevier. 2022; 54(9).
Eva María Satué Gracia AVC. Indicadores pronósticos de la COVID-19 en atención primaria. Elsevier. 2022; 54(7).
Fernández-Naranjo EOP. Impacto de la COVID-19 en el Ecuador: De Los Datos Inexactos a Las Muertes en Exceso. Revista ecuatoriana de neurologia. 2020; 29(2).
Chauca R. La covid-19 en Ecuador: fragilidad política y precariedad de la salud pública*. Scielo. 2021; 28(2).
Ronny Alexander Rodríguez-Pincay ÁNPVDYPCASPB. Características epidemiológicas e demográficas dos pacientes com Covid-19: um estudo comparativo entre Jipijapa e Puerto López. Dialnet. 2020; 6(4).
Zurisadai Raquel García Osorno LÁPM. Vacunas contra la COVID-19. SCIELO. 2021; 19(3).
L. Urbiztondo EbGM. Vacunas contra el coronavirus. Elsevier. 2020; 21(1).
Irma Casas GM. La vacunación de la COVID-19. Elsevier. 2021; 156(10).
Anamary Suárez Reyes CAVV. Características y especialización de la respuesta inmunitaria en la COVID-19. Scielo. 2020; 63(4).
Walter Patricio Castelo-RivasI* KJCCKJRCSATC. Reacciones adversas en personas vacunadas contra la COVID-19 pertenecientes al Recinto Umpechico Ecuador. Revista informatica ciencia. 2022; 101(4).
Nataniel Aldo Chaparro Mérida DMSAOFL. SEGURIDAD DE LAS VACUNAS CONTRA LA COVID-19. Scielo. 2021; 38(4).
García-Salido A. Revisión narrativa sobre la respuesta inmune frente a coronavirus: descripción general, aplicabilidad para SARS-COV-2 e implicaciones terapéuticas. PubMed. 2020; 93(1).
CRISCI JVyKL. Las citas bibliográficas en la evaluación de la actividad científica: significado, consecuencias y un marco conceptual alternativo. Scielo. 2020; 55(3).
Koirala , Jin Joo , Khatami A, Chiu C, Britton. Vaccines for COVID-19: The current state of play. Paediatric Respiratory Reviews. 2020; 35: p. 43-49.
Deloria , Wonodi. Oxford–AstraZeneca COVID-19 vaccine efficacy. Lancet. 2021; 397(10269): p. 72–74.
Tavilani , Abbasi , Kian , Darini , Asefy. COVID-19 vaccines: Current evidence and considerations. Elsevier. 2021; 12: p. 100124.
Carneiro , Sousa , Monteiro. The COVID-19 vaccine development: A pandemic paradigm. Virus Research. 2021; 301: p. 198454.
Shahzamani , Mahmoudian , Ahangarzadeh , Mehdi M, Beikmohammadi , Bahrami , et al. Vaccine design and delivery approaches for COVID-19. International Immunopharmacology. 2021; 100(108086).
Qamar , Rukh , Khan. Vaccines for Covid‐19: An insight on their effectiveness and adverse effects. J Med Virol. 2022; 94(8): p. 3554–3560.
Watson , Barnsley , Toor , Hogan , Winskill , Ghani. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Diseases. 2022; 22(9): p. 1293–1302.
Saadh , Aldeen. Efficacy of COVID-19 vaccines. Microbial Pathogenesis. 2022; 171(105729).
Rahman , Masum , Wajed , Talukder. A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges. Virusdisease. 2022; 33(1): p. 1–22.
Kudlay D, Svistunov. COVID-19 Vaccines: An Overview of Different Platforms. Bioengineering (Basel). 2022; 9(2): p. 72.
Whitaker HJ, Tsang RSM, Byford R, Andrews N, Sherlock , Sebastian , et al. Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups. journal infection. 2022; 84(675-683): p. 675–683.
Muhar , Nehira J, Malhotra , Kotchoni. The Race for COVID-19 Vaccines: The Various Types and Their Strengths and Weaknesses. PubMed. 2023; 36(4): p. 953–966.
Pérez F, Valcárcel , Arias , Astudillo , Bruno , Herrera , et al. Effectiveness of COVID-19 vaccines in Ecuador: A test-negative design. Elsevier. 2023; 15: p. 100404.
Chinta , Rodriguez M, Shaban M, Pandey , Jaquez M, Vittorio. COVID-19 therapy and vaccination: a clinical narrative review. PubMed. 2023; 12: p. 7-2.
Ramasamy M, Minassian A, Ewer K, Flaxman A, Folegatti P, Owens P, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. The Lancet. 2020; 396(10267).
Rios C, Mendez J, Estigarribia G, Aguilar G, Martínez P. Efectos secundarios de las vacunas anti COVID-19 en personal de salud de Paraguay: estudio exploratorio. Rev. salud publica Parag. 2021; 11(2).
Acosta F, Vinces T, Triviño S. Eficacia y efectos secundarios de la vacuna contra el COVID 19. Dominio de las ciencias. 2021; 7(2): p. 1079-1087.
Pérez H, Rodriguez D. Eficacia y efectos secundarios de la vacuna Sinovac contra el covid-19 en el Ecuador. Dominio de las ciencias. 2021; 7(5).
Mohammed I, Nauman , Paul P, Ganesan , Chen KH, Muhammad , et al. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review. Human Vaccines & Immunotherapeutics. 2022; 18(1).
Mohsin M, Mahmud S, Uddin A, Hasan P, Muyeed A, Taif M, et al. Side effects of COVID-19 vaccines and perceptions about COVID-19 and its vaccines in Bangladesh: A Cross-sectional study. Elsevier. 2022; 12(100207).
Yan MM, Zhao H, Li ZR, Chow JW, Zhang Q, Qi YP, et al. Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS. Front. Pharmacol. 2022; 13.
Trougakos I, Terpos E, Alexopoulos H, Kastritis E, Andreakos E, Dimopoulos M. Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis. Trends in molecular medicine. 2022; 28(7): p. 542-554.
Hosseini , Askari N. A review of neurological side effects of COVID-19 vaccination. European Journal of Medical Research. 2023; 28(102).
Dhamanti , Suwantika A, Adlia A, Yamani N, Yakub F. Adverse Reactions of COVID-19 Vaccines: A Scoping Review of Observational Studies. International Journal of General Medicine. 2023; 16: p. 609—618.
Llenera C, Aucanshala E. Efectos adversos post vacunación contra el COVID-19 en adolescentes. Salud, ciencia y tecnologia. 2023; 3.
Jamshidi , Asgary , Yazdizadeh A, Tavakoli , Zali A, Mehrazi , et al. Personalized predictions of adverse side effects of the COVID-19 vaccines. Heliyon. 2023; 9(1).
Facme. Recomendaciones diagnóstico-terapéuticas del grupo de trabajo de expertos de FACME ad-hoc sobre el manejo de la trombosis venosa cerebral relacionada con la vacunación frente a COVID-19 Recomendacionesde diagnóstico y tratamiento del grupo de trabajo de e. Elsevier. 2021; 36(6).
Marta Sofía Becker CBMS. Reacciones adversas post vacunación, y eventual infección por Covid-19 en odontólogos. Scielo. 2021; 3(2).
Rosa Alicia Galeano KAONCDRRL. Efectos adversos a las vacunas contra la COVID19 en Paraguay en el 2021. Bvsalud. 2021; 5(5102).
Paraskevi C. Fragkou DD. Complicaciones graves de las vacunas COVID-19: una minirevisión. Elsevier. 2021; 12.
Marta Sofia Becker CBMS. Reacciones adversas post vacunación, y eventual infección por covid-19 en odontologos. Bvsalud. 2021; 3(2).
Pinto SMG. Reacciones adversas vinculadas a la vacuna SINOPHARM en personal de salud del Hospital Regional Policial Arequipa Julio Pinto Manrique. Dialnet. 2022; 2(5).
Natalia Aguirre CGAM. Reacciones adversas asociadas a vacunas contra la COVID-19. Scielo. 2021; 35(3).
Cristina Palomo-Palomo DGEAPGJEG. Reactogenicity of the BNT162b2 mRNA vaccine (Pfizer-BioNTech) against COVID-19 in workers of a tertiary hospital. Scielo. 2022; 46(3).
lena García Alonso CSPAGLRAMGM. Análisis de las reacciones adversas a la vacuna contra COVID-19 en la población de la Zona Básica de Salud de Cantalejo. mgyft. 2022; 11(5).
Pérez Contreras Norma PCISGSRHLMVPDA. Eventos adversos asociados a post vacunas covi19 en pacientes de una unidad medica familiar. dialnet. 2023; 11(1).
María Esther Ruiz-Sayritupac de Nué MdCGL. Authorization procedure for COVID-19 vaccines: United States of America, European Union and Latin America. Scielo. 2023; 64(1).
Gomez EB. Combination of COVID-19 vaccines and their efficacy: a theoretical proposal. PubMed. 2022; 46(14).
José E. López-Contreras PPCJMRFECVJCLRMBB. Incidence and factors associated with early and late adverse reactions after the first dose of Pfizer-BioNTech vaccine among healthcare workers. Scielo. 2023; 91(1).
Ana Carolina Martínez-Roa LLRaIYLN. Incidencia de efectos adversos de la vacuna contra COVID-19 Pfizer/BioNTech: estudio de cohorte retrospectivo. PubMed. 2023; 61(2).
Homedes AUH. Desigualdad en el acceso a las vacunas: el fracaso de la respuesta mundial a la pandemia de COVID-19. Scielo. 2023; 18(06).
Anton Pottegård 1LCLØKJDMAJHOLGTHLPLSVAPLPHTRWAH. Eventos arteriales, de tromboembolismo venoso, trombocitopenia, y hemorragia después de la vacunación con la vacuna de OxfordAstraZeneca ChAdOx1-S en Dinamarca y Noruega: estudio basado en una cohorte poblacional. Infomed. 2021; 373(111).
Danza A E. Recomendaciones diagnóstico-terapéuticas del grupo de trabajo de expertos de FACME ad-hoc sobre el manejo de la trombosis venosa cerebral relacionada con la vacunación frente a COVID-19 ☆. PubMed. 2021; 36(6).
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 BIOSANA Health Scientific Journal. ISSN 2960-8481
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
